ArticleDementia and geriatric cognitive disorders2026
Examining the Decision to Take a Dementia Risk Test: Considerations for Privacy in Screening At-Home.
Article in Dementia and geriatric cognitive disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionEarly methods for screening and monitoring Alzheimer's disease and other dementias are being developed in response to emerging interventions that target preclinical disease stages. This study aimed to determine adults' willingness to be screened for dementia risk, and the extent to which privacy of results relative to medical or insurance providers impacted their decision.
methodsAmazon MTurk was used to survey 527 adults nationwide.
resultsLogistic regression and random forest models identified that, overall, participants were willing to take such a test, with older age being associated with increased willingness. However, non-white participants were over 3 times more likely than white participants to agree to be screened only if their results were not shared with a medical provider/insurer.
conclusionFindings suggest that more inclusive and affordable methods for dementia risk screening and monitoring need to be developed for real-world at-home use without engaging medical providers or insurance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.